Fundraising Fox

Cajalneuro

Seattle, US Β· 2 known investors

Cajal Therapeutics is a biotech company developing novel therapies through the translation of neuroscience research into therapeutic treatments for patients.

BiotechDeep TechDigital Health

Founders & leadership

AD
Andrew DervaninCo-Founder and Co-Chief Executive Officer
IPIan Peikon
Ian Peikonin𝕏Co-Founder and Co-Chief Executive OfficerVenture Partner at Lux Capital
RH
Rob HershbergCo-Founder and Executive Chairman

Investors Β· 2

Lux Capitalβœ“ verifiedNew York Β· $100K – $100M
Dolby Family VenturesreportedSan Francisco

Frequently asked questions

What does Cajalneuro do?
Cajal Therapeutics is a biotech company developing novel therapies through the translation of neuroscience research into therapeutic treatments for patients.
Who founded Cajalneuro?
Cajalneuro was founded by Andrew Dervan, Ian Peikon, Rob Hershberg.
Who are Cajalneuro's investors?
Cajalneuro's investors include Lux Capital, Dolby Family Ventures.
Where is Cajalneuro headquartered?
Cajalneuro is headquartered in Seattle, US.